Integra LifeSciences Holdings Corporation (IART)
Healthcare
- Fundamental
- 2
- Sentiment
- 3
- Technical
- 2
Do Nothing: fundamentalScore is 2 (below required floor of 3); strategy requires fundamentalScore ≥ 3 before any bullish entry.
Company overview
Integra LifeSciences Holdings Corporation is a medical technology company that develops and distributes advanced surgical implants and instruments globally. It operates through Codman Specialty Surgical, offering neurosurgical products, and Tissue Technologies, focusing on regenerative technology for wound treatment and surgical tissue repair. The company serves a diverse clientele including hospitals and surgical centers worldwide.
Fundamental
weakIntegra LifeSciences has a fundamental score of 2, indicating concerns with profitability and leverage.
Integra LifeSciences has a fundamental score of 2, indicating concerns with profitability and leverage.
Sentiment
fairMedia and analyst sentiment is mixed, balancing profitability narratives against concerns over FX and leverage.
The key near-term driver is the announced Q2’26 earnings update (7/29), but the last ~14d media read is mixed/neutral (profitability/margin repair vs FX/outlook-trim and leverage concerns) versus a mildly positive 30–90d baseline; this conflicting narrative keeps conviction capped (moderate flag → max 3). Legal/investigation screen found no regulator-confirmed actions in the last 90d, though court-case discovery was access-limited (CAPTCHA).
Technical
weakThe stock is in a bearish phase, trading below key moving averages with weak momentum indicators.
Score 2/5: IART remains in a bearish short-term repair phase after the 2026-07-29 earnings gap. Price is below SMA20 18.44, SMA50 17.79, EMA9 17.75, EMA21 18.06 and daily VWAP 17.37, while RSI14 44.29 and MACD -0.09 versus 0.15 signal show momentum has not repaired. Price is still above SMA200 13.39 and liquidity is healthy, but ADX14 42.15 says the active trend still favors sellers.
You’re looking at 2026-08-07 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.